Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Drugs » Self-Management

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Pioglitazone Demonstrates Significant Improvements in Cardiovascular Outcomes
Posted: Thursday, September 21, 2006
Actos® (pioglitazone HCl), an oral antidiabetic medication, demonstrated significant cardiovascular benefits in reducing the risk of heart attack and/or stroke and acute coronary syndrome in patients with type 2 diabetes.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 2- Ramipril Arm)
Posted: Thursday, September 21, 2006
The Dream Study also found that the ACE-inhibitor Altace (ramipril) does not prevent type 2 diabetes in patients with impaired glucose metabolism.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 1-Rosiglitazone Arm)
Posted: Thursday, September 21, 2006
The results of a major study released: The Dream Study (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) with over 5000 patients Rosiglitazone reduced the risk of developing type 2 diabetes by 62 percent (p<0.0001) relative to placebo among people at high risk of developing type 2 diabetes.

Significant Glucose-Lowering Efficacy Of JANUVIA™ in Phase III Study
Posted: Thursday, September 21, 2006
New data presented for the first time at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated a mean reduction in A1C of 2.1% from a mean baseline A1C of 8.8% and a reduction of 2.9% for those with a mean A1c of 11.2%.

Galvus® Demonstrates Powerful Blood Sugar Reductions In Phase III Studies
Posted: Thursday, September 21, 2006
Galvus dropped A1c by 1.8% without weight gain.

Adherence to Preventive Medications Reduces Risk of Diabetes
Posted: Wednesday, September 13, 2006
Participants who were compliant had a 38.2% reduced risk of developing diabetes.

Blacks Have Poorer Control of Diabetes Than Whites
Posted: Thursday, August 31, 2006
A new review of the data from 56,000 patients shows that blacks with diabetes tend to have worse control of the disease than whites.

States Ask FDA to OK Generic Insulin
Posted: Thursday, August 17, 2006
Four governors, looking to ease drug costs under state programs, petitioned the U.S. Food and Drug Administration to provide guidelines for generic versions of insulin and human growth hormone.

`Mr. Diabetes®' Talks the Talk and Walks the Walk
Posted: Wednesday, August 09, 2006
Walking down Commonwealth Avenue, on approximately the 7,500th mile of his perimeter walk around the United States, Andy ``Mr. Diabetes®" Mandell spotted his latest target.

``Hi, may I talk to you for a minute?" Mandell asked the young man walking toward him. ``Do you know anyone with diabetes?"

Treatment Guidelines Favor Early Metformin Then Insulin for Type 2 Diabetes
Posted: Wednesday, August 09, 2006
Metformin should be prescribed along with lifestyle intervention as soon as patients are diagnosed with type 2 diabetes and if A1c cannot be brought down to below 7%, within 2-3 months, then insulin as the second-line drug.

Page 49 of 52
 |<   <<   <  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement